ABCL
Abcellera Biologics Inc
14.80$
+6.5%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Abcellera Biologics Inc (ABCL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -131 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 3.6 | 2.7 | 23 | 245 | 277 | -44 | -109 | -131 | |
| 0.9 | 1.8 | 5.3 | 17 | 33 | 31 | 97 | 22 | |
| 0.6 | 0.9 | 8.4 | 31 | 49 | 64 | 68 | 56 | |
| 0.4 | 1.1 | 15 | 32 | 56 | – | – | – | |
| 1.9 | 2.0 | -117 | 42 | 30 | 13 | -26 | -71 | |
| 5.3 | 4.0 | 15 | 58 | 73 | 78 | 78 | 43 | |
| -5.3 | -5.8 | -120 | -332 | -353 | -221 | 121 | 88 | |
| – | 0.0 | – | – | – | – | – | – | |
| – | 0.0 | 0.0 | 0.0 | – | – | – | – | |
| 2.0 | 0.2 | 85 | -1.0 | -0.3 | 12 | – | – | |
| 12 | 0.2 | 684 | -3.9 | -1.6 | 10 | 13 | 14 | |
| 10 | -2.9 | 587 | -93 | -86 | -254 | 23 | -28 | |
| -1.7 | -1.3 | 8.0 | 186 | 205 | -121 | -187 | -174 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.